Omicron variant-specific vaccine
Scope
Date
~
-
Tech, Media & Telecom
LG Uplus to debut university-specific metaverse platforms early next year
South Korea's mobile telecom operator LG Uplus said on Thursday that it would introduce a specialized metaverse platform for which all universities ...
Dec 15, 2022 (Gmt+09:00)
-
Artificial intelligence
LG Group think tank unveils breakthrough AI tech Exaone
LG AI Research, the artificial intelligence (AI) think tank of South Korea's LG Group, on Thursday unveiled Exaone, a gigantic AI technology that ra...
Dec 09, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience seeks WHO nod for prompt COVID vaccine sale
SK Bioscience Co., the biopharmaceutical unit of South Korea’s No. 2 conglomerate SK Group, sought approval from the World Health Organization...
Sep 08, 2022 (Gmt+09:00)
-
Corporate governance
Activist fund steps up pressure for SM Ent's governance reform
Align Partners Capital Management, a South Korean activist fund, has threatened legal action against entertainment behemoth SM Entertainment Co., re...
Aug 18, 2022 (Gmt+09:00)
-
Korean chipmakers
Samsung presents Texas with $200 bn chip investment plan proposition
Samsung Electronics Co., the world’s top memory chipmaker, has presented a tax break proposal to the State of Texas as part of its plan to inv...
Jul 22, 2022 (Gmt+09:00)
-
Corporate investment
Korea to raise cash support on foreign investments in key sectors
South Korea plans to spend more cash on attracting foreign investments in high-tech and core supply chain industries as foreign direct investment to...
Jul 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
SK Bioscience wins marketing license for Korea's first COVID-19 vaccine
South Korea’s SK Bioscience Co., a biopharmaceutical unit of SK Group, has won marketing authorization for its COVID-19 vaccine from the Minis...
Jun 29, 2022 (Gmt+09:00)
language -
Korean startups
Startups serving specific markets thrive: SaaS, fantech, veganism
Vertical service providers are dominating South Korea’s venture business ecosystem, in a study of the country’s early stage startups by ...
Jun 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean drugmakers close to commercializing COVID-19 vaccine, pill
South Korea’s biopharmaceutical companies are close to commercializing a COVID-19 vaccine and treatment pill as they are on the brink of compl...
Apr 25, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector
SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...
Mar 31, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience becomes first to win domestic COVID-19 vaccine contract
SK Bioscience Co. said it reached a deal with Korea’s disease control agency to supply 10 million doses of the country’s first experimen...
Mar 22, 2022 (Gmt+09:00)
language -
Entertainment
BTS returns to Korean stage for 1st time since 2019
SEOUL — In the latest sign that life is going back to something that resembles the pre-pandemic past, BTS is returning to the stage in Seoul.The...
Feb 25, 2022 (Gmt+09:00)
-
Korean stock market
Korea’s reopening stocks shine despite surging Omicron cases
South Korea’s reopening stocks rallied even as the local COVID-19 cases hit record-highs with the spread of the Omicron variant. Investors rai...
Feb 08, 2022 (Gmt+09:00)
-
Earnings
SK Bioscience posts record earnings driven by COVID-19 vaccines
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, has posted record 2021 revenue and operating profit, boosted by contrac...
Feb 08, 2022 (Gmt+09:00)
-
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
COVID-19
Korea approves export of Samsung Biologics-made Moderna vaccine
South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...
Dec 14, 2021 (Gmt+09:00)
language -
Pharamaceuticals, biotech
Celltrion to conduct tests on Omicron variant detected in Korea
Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...
Dec 06, 2021 (Gmt+09:00)
-
Aerospace & Defense
Korea’s Hanwha Aerospace to develop small rocket system
Hanwha Aerospace Co., a unit of South Korean conglomerate Hanwha Group, is developing system technology for small projectiles that launch a satellit...
Dec 06, 2021 (Gmt+09:00)
-
COVID-19
Korea’s reopening stocks jump on easing Omicron woes
South Korea’s reopening stocks surged on Dec. 3 as US President Joe Biden’s plans to curb the Omicron variant of COVID-19 exclude lockdo...
Dec 03, 2021 (Gmt+09:00)
-
Business & Politics
Jay Y. Lee meets Verizon CEO and Moderna co-founder
Samsung Electronics Co. Vice Chairman Jay Y. Lee has met with biopharmaceutical conglomerate Moderna’s co-founder and telecommunications g...
Nov 18, 2021 (Gmt+09:00)
language -
Business & Politics
Samsung heir Lee on US trip for foundry investment, COVID vaccines
Jay Y. Lee, vice chairman and de facto leader of South Korea’s top conglomerate Samsung, has embarked on a business trip to North America to f...
Nov 14, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics-made Moderna vaccine available to Koreans this week
Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...
Oct 27, 2021 (Gmt+09:00)
language -
Moderna co-founder
Giving away patents not in line with capitalist society
WASHINGTON D.C. -- US-based biotechnology company Moderna Inc. wasn’t a household name until the beginning of last year, when its fate changed...
Oct 12, 2021 (Gmt+09:00)
-
Asia’s Covid-19 Success Stories Warily Ponder Post-Vaccination Moves
Earlier this month, Singapore reached a Covid-19 milestone: The fully vaccinated portion of the population crossed 80%. But instead of moving ahead wi...
Sep 15, 2021 (Gmt+09:00)
-
COVID-19
Samsung Biologics gears up to produce mRNA drug substance
South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...
Sep 01, 2021 (Gmt+09:00)
language -
Future mobility
S.Korean govt to spend $5.4 bn to develop sensors, improve EV repair
South Korean government will spend 6.3 trillion won ($5.4 billion) next year in supporting the state-designated Big 3 industries: future vehicles, n...
Aug 30, 2021 (Gmt+09:00)
-
COVID-19
Korea electronics, auto sectors hit by triple whammy
South Korea's electronics and auto industries, the two main pillars of Asia’s fourth-largest economy, are losing growth momentum. Demand is sl...
Aug 22, 2021 (Gmt+09:00)
language -
Automobiles
Carmaker stocks hit speed bump of chip shortage, Delta variant
Shares in global carmakers such as Hyundai Motor Co. and Toyota Motor Corp. are tumbling. The automotive chip shortage is expected to deteriorate fu...
Aug 20, 2021 (Gmt+09:00)
-
COVID-19
SK Bioscience to kick off phase 3 vaccine trials
SK Bioscience Co. has received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for phase 3 clinical trials of its COVID-19...
Aug 10, 2021 (Gmt+09:00)
language